Premier Bionics plans AIM listing

Premier Bionics (ASX:PBI) is seeking to list on London's Alternative Investment Market (AIM).

It is expected that its admission on AIM will take place on or around November 16, with the company's ordinary shares and options continuing to be traded on the ASX.

"The AIM listing is very strategic to us because we're planning Medic Vision's expansion in the UK and Ireland and then ultimately Europe," said Medic Vision CEO Ross Horley.

Medic Vision -- a 100 per cent owned subsidiary of Premier Bionics -- is expanding sales of its virtual reality simulators and skills centre development projects in the UK and European markets.

"As a result we need a good corporate presence in the region, particularly in London."

The dual listing is also expected to give Premier Bionics greater international exposure and the opportunity to gain direct access to UK capital markets.

Premier Bionics has appointed Corporate Synergy as its broker for the listing.